GCVI Summit 2018
Skip Content

Investment

5 December 2017

Phase Genomics points out $1m

The company is the first to have spun out of University of Washington’s Genome Sciences department and will use the cash to hire additional staff.

Author: Thierry Heles, editor

Phase Genomics, a US-based biotech spinout of University of Washington, has raised $1m from Washington Research Foundation, which invests in companies linked to universities in the US state, and Congruent Ventures, Geekwire reported on Sunday.

Founded in 2015, Phase Genomics was the first spinout to emerge out of the Genome Sciences department at the university. The company has created technology to identify individual micro-organisms and viruses and figure out which of them are commingling inside cells.

The spinout was co-founded by Ivan Liachko and Shawn Sullivan, who launched the business out of the university’s CoMotion biotech incubator, where the company remains.

Phase Genomics currently has three products and services for DNA sequencing on the market, and hopes to launch additional ones in the near future. The funding will be used to hire additional staff.

Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed